Fingerprint
Dive into the research topics where Bella Kaufman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation
Dadiani, M., Friedlander, G., Perry, G., Balint-Lahat, N., Gilad, S., Morzaev-Sulzbach, D., Shenoy, A., Bossel Ben-Moshe, N., Pavlovsky, A., Bernstein-Molho, R., Domany, E., Barshack, I., Geiger, T., Kaufman, B. & Gal-Yam, E. N., Dec 2025, In: Molecular Oncology. 19, 12, p. 3665-3684 20 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Divergence of mutational signatures in association with breast cancer subtype
Perry, G., Dadiani, M., Kahana-Edwin, S., Pavlovski, A., Markus, B., Hornung, G., Balint-Lahat, N., Yosepovich, A., Hout-Siloni, G., Jacob-Hirsch, J., Sklair-Levy, M., Friedman, E., Barshack, I., Kaufman, B., Gal-Yam, E. N. & Paluch-Shimon, S., Nov 2022, In: Molecular Carcinogenesis. 61, 11, p. 1056-1070 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)
Paluch-Shimon, S., Cardoso, F., Partridge, A. H., Abulkhair, O., Azim, H. A., Bianchi-Micheli, G., Cardoso, M. J., Curigliano, G., Gelmon, K. A., Gentilini, O., Harbeck, N., Kaufman, B., Kim, S. B., Liu, Q., Merschdorf, J., Poortmans, P., Pruneri, G., Senkus, E., Sirohi, B. & Spanic, T. & 3 others, , Nov 2022, In: Annals of Oncology. 33, 11, p. 1097-1118 22 p.Research output: Contribution to journal › Article › peer-review
Open Access185 Scopus citations -
Genetic Syndromes and RT for Breast Cancer
Bernstein-Molho, R., Kaufman, B. & Wyld, L., 1 Jan 2022, Breast Cancer Radiation Therapy: A Practical Guide for Technical Applications. Springer International Publishing, p. 373-381 9 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
1 Scopus citations -
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
OlympiA Clinical Trial Steering Committee and Investigators, 1 Dec 2022, In: Annals of Oncology. 33, 12, p. 1250-1268 19 p.Research output: Contribution to journal › Article › peer-review
Open Access360 Scopus citations